COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

The market opportunities in the Global Uterine Cancer Therapeutics & Diagnostics Market include the increased demand for ...

In a study published in the Journal of Extracellular Vesicles, scientists from the UF Health Cancer Institute have found a way to make treatment for a notoriously aggressive breast cancer more ...

Researchers have demonstrated that microscopic drug delivery containers can be magnetically steered to their targets, advancing the development of precision medicine for treating diseases such as ...

Targeted drug delivery has long been a cornerstone goal of modern medicine—sending therapies exactly where they’re needed while sparing healthy tissues. Yet creating treatments that can decide when ...

Scientists have developed a DNA nanoflower that delivers chemotherapy and gene therapy directly to breast cancer cells, boosting effectiveness while reducing side effects in early tests. Image Credit: ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

A new breakthrough from researchers at the University of Cambridge removes the dangers involved in a process called STING, in which the body's own immune system can be enlisted to fight cancer. The ...